Gi-Byoung Nam
Quick facts
Marketed products
- Edoxaban Monotherapy
- Edoxaban plus Single Antiplatelet Agent · Cardiovascular
Edoxaban inhibits Factor Xa to prevent blood clot formation, while a single antiplatelet agent (such as aspirin or clopidogrel) blocks platelet aggregation, providing dual antithrombotic protection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: